Showing results (161-170 of 185) with videos related to
Sort By:
Pageof 19
Diabetes Research and Clinical Practice|August 6, 2002
Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic footA Piaggesi, L Rizzo, F Golia, et al.Journal of Endocrinological Investigation|June 15, 2005
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselvesM Marinò, E Morabito, M A Altea, et al.Journal of Endocrinological Investigation|July 11, 2020
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathyF Nicolì, G Lanzolla, M Mantuano, et al.The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid diseaseL D Kohn, K Suzuki, W H Hoffman, et al.Journal of Endocrinological Investigation|August 23, 2018
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathyM Marinò, G Rotondo Dottore, I Ionni, et al.The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized studyC Marcocci, L Bartalena, M L Tanda, et al.La Radiologia Medica|August 4, 2007
Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidismS Mazzeo, C Cappelli, D Caramella, et al.Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.The New England Journal of Medicine|January 8, 1998
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathyL Bartalena, C Marcocci, F Bogazzi, et al.Journal of Endocrinological Investigation|June 26, 2020
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves' Disease: results of a pilot studyG Lanzolla, D Ricci, F Nicolì, et al.Pageof 19